| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9004602 | Biomedicine & Pharmacotherapy | 2005 | 5 Pages |
Abstract
Curcumin synergistically augments the growth inhibition inserted by celecoxib in pancreatic cancer cells expressing COX-2. The synergistic effect was mediated through inhibition of COX-2. This may enable the use of celecoxib at lower and safer concentrations and may pave the way for a more effective treatment in this devastating disease.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Lev-Ari, H. Zinger, D. Kazanov, D. Yona, R. Ben-Yosef, A. Starr, A. Figer, N. Arber,